PELNSEPiramal Enterprises Limited· PharmaceuticalsMediumNeutral
Announced Sat, 7 Jun · 17:36 IST

Integrated Annual Report for the financial year 2024-25 and Notice of the 78th Annual General Meeting of the Company

Board & Shareholder Meetings View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Piramal Enterprises has filed its first-ever Integrated Annual Report for FY2024-25 along with the notice for its 78th AGM, scheduled for June 30, 2025 at 3:00 PM via video conferencing. Consolidated Assets Under Management (AUM) grew 17% year-on-year to ₹80,689 crore, beating the company's own 15% growth target. Retail AUM surged 35% to ₹64,652 crore while legacy wholesale book shrank to ₹6,920 crore (now just 9% of total book). The company swung back to a consolidated net profit of ₹485 crore versus a ₹1,684 crore loss in FY24. The 78th AGM will consider a dividend payout of ₹248 crore. Key strategic update: the proposed merger with wholly-owned subsidiary Piramal Finance Limited has received RBI approval and is currently with NCLT, expected to conclude by around September 2025, creating a unified upper-layer NBFC.

Likely market impact

Shareholders can vote on the proposed ₹248 crore dividend at the AGM. The merger with Piramal Finance will simplify the group structure and give PEL shareholders direct ownership in the consolidated lending business, while unlocking ~₹14,500 crore in tax shields from carry-forward losses. Strong FY25 results and FY26 guidance (AUM targeted to cross ₹1 lakh crore, PAT over ₹1,300 crore) signal continued growth momentum.